We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.9B
AUM Growth
+$620M
Cap. Flow
-$8.35M
Cap. Flow %
-0.14%
Top 10 Hldgs %
23.55%
Holding
3,465
New
250
Increased
687
Reduced
2,249
Closed
176

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$47.2M
2
MSFT icon
Microsoft
MSFT
+$38.2M
3
AAPL icon
Apple
AAPL
+$37M
4
AMZN icon
Amazon
AMZN
+$35.5M
5
CTRA
Coterra Energy
CTRA
+$34.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.44%
2 Technology 20.51%
3 Financials 13.46%
4 Industrials 10.73%
5 Healthcare 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBCH
2676
Turtle Beach Corp
TBCH
$220M
$3.76K ﹤0.01%
302
+68
+29% +$806
RILY icon
2677
BRC Group Holdings
RILY
$283M
$3.75K ﹤0.01%
+467
New +$3.97K
ADTN icon
2678
Adtran
ADTN
$618M
$3.75K ﹤0.01%
270
-213
-44% -$3.32K
TNXP icon
2679
Tonix Pharmaceuticals
TNXP
$226M
$3.75K ﹤0.01%
294
-156
-35% -$2.01K
TBI
2680
Trueblue
TBI
$286M
$3.74K ﹤0.01%
536
-412
-43% -$2.29K
BKKT icon
2681
Bakkt Inc
BKKT
$372M
$3.73K ﹤0.01%
477
+39
+9% +$349
RICK icon
2682
RCI Hospitality Holdings
RICK
$222M
$3.72K ﹤0.01%
136
+15
+12% +$380
QTRX icon
2683
Quanterix
QTRX
$129M
$3.71K ﹤0.01%
860
-415
-33% -$1.35K
VYGR icon
2684
Voyager Therapeutics
VYGR
$210M
$3.71K ﹤0.01%
1,060
-482
-31% -$1.83K
IVVD icon
2685
Invivyd
IVVD
$243M
$3.7K ﹤0.01%
+4,242
New +$5.32K
TNDM icon
2686
Tandem Diabetes Care
TNDM
$1.38B
$3.7K ﹤0.01%
245
-194
-44% -$3.39K
PLPC icon
2687
Preformed Line Products
PLPC
$2.01B
$3.69K ﹤0.01%
9
-71
-89% -$24.9K
PDYN icon
2688
Palladyne AI
PDYN
$285M
$3.68K ﹤0.01%
605
-397
-40% -$2.63K
PSFE icon
2689
Paysafe
PSFE
$340M
$3.67K ﹤0.01%
491
-551
-53% -$4.31K
LIF
2690
Life360
LIF
$3.51B
$3.65K ﹤0.01%
66
-68
-51% -$3.02K
HLLY icon
2691
Holley
HLLY
$361M
$3.64K ﹤0.01%
1,429
-1,100
-43% -$3.12K
CCB icon
2692
Coastal Financial
CCB
$756M
$3.64K ﹤0.01%
47
-37
-44% -$2.78K
ACRS icon
2693
Aclaris Therapeutics
ACRS
$892M
$3.63K ﹤0.01%
686
-2,351
-77% -$10.5K
ARCT icon
2694
Arcturus Therapeutics
ARCT
$444M
$3.63K ﹤0.01%
540
-71
-12% -$560
RGNX icon
2695
Regenxbio
RGNX
$578M
$3.62K ﹤0.01%
302
-1,257
-81% -$10.4K
ESCA icon
2696
Escalade
ESCA
$284M
$3.59K ﹤0.01%
191
-147
-43% -$2.72K
GENB
2697
Generate Biomedicines
GENB
$2.04B
$3.58K ﹤0.01%
+212
New +$2.89K
UMAC icon
2698
Unusual Machines
UMAC
$1.3B
$3.57K ﹤0.01%
+160
New +$2.96K
ALCO icon
2699
Alico
ALCO
$295M
$3.56K ﹤0.01%
86
-101
-54% -$4.19K
CRVS icon
2700
Corvus Pharmaceuticals
CRVS
$1.17B
$3.56K ﹤0.01%
238
-180
-43% -$2.5K

Similar funds

Sterling Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Sterling Capital Management held 3,465 positions worth $5.9B, up 12% from $5.28B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sterling Capital Management's Q2 2026 filing shows 250 new, 687 increased, 2,249 reduced and 176 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M. The largest sale was Marvell Technology, an estimated $47.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Sterling Capital Management's largest Q2 2026 buy was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M.
  • Sterling Capital Management added most to Philip Morris in Q2 2026, an estimated $43.1M increase.
  • Sterling Capital Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $47.2M.
  • Sterling Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $34.4M.
  • Sterling Capital Management's ten largest holdings make up 24% of its $5.9B portfolio in Q2 2026.
  • Sterling Capital Management opened 250 new positions and closed 176 in Q2 2026.
  • Sterling Capital Management's portfolio value rose 12% quarter-over-quarter to $5.9B.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.